2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Saturday, December 12, 2026
05:30 p.m. - 07:30 p.m.
MCCNO - Hall F
Technology and Procedures, Assays, Imaging, Omics Technologies, Bioinformatics, Cell Expansion, Computational Biology, Biological Processes, Genomics, Hematopoiesis, Immune Mechanism, Metabolism, Molecular Biology, Diseases, Myeloid Malignancies, Chronic Myeloid Malignancies, Research, Fundamental Science, Translational Research, Study Population, Human, Animal Model
PAPER

1362 Aging enhances IL-1β responsiveness in human bone marrow hematopoietic stem cells

Monica Kasbekar, MD, PhD, Jun Hou Fung, PhD2, Melissa A. Proven3, Raul Rabadan, PhD4, Emmanuelle Passegue, PhD5
1 Columbia University Irving Medical Center, New York, New York, United States
2 Columbia University Irving Medical Center, New York, New York, United States
3 Columbia University Irving Medical Center, New York, New York, United States
4 Columbia University Irving Medical Center, New York, New York, United States
5 Columbia University Irving Medical Center, New York, New York, United States
Human hematopoietic stem cells (HSCs) demonstrate age-related molecular changes, such as increased inflammatory pathway activation; however, the functional consequences on bone marrow (BM) HSC behavior remain incompletely understood. To address this question, we characterized 104,224 human HSCs (CD34+/CD38-/CD45RA-/CD90+) from 20 vertebral BM samples spanning 8–66 years of age using single-cell RNA-sequencing. We identified an age-dependent increase in interleukin-1 (IL-1)–mediated signaling within the HSC compartment. We next examined the effects of IL-1β on human BM HSCs across multiple model systems. Although aging diminished overall HSC expansion in liquid culture, IL-1β preferentially enhanced expansion and promoted myeloid differentiation in old HSCs relative to young. Mechanistically, we observed age-dependent augmentation of IL-1β–induced NF-κB activation in old HSCs. Bulk RNA-sequencing of IL-1β–treated HSCs demonstrated enrichment of NF-κB target genes in old samples, and single-cell ATAC-sequencing revealed increased accessibility of NF-κB–associated transcription factor motifs, including REL and RELA. Consistent with these findings, confocal microscopy demonstrated increased nuclear localization of p65 following IL-1β treatment in old HSCs. To evaluate in vivo relevance, we transplanted human HSCs into NSG mice and treated engrafted recipients with intraperitoneal IL-1β for 7 days. IL-1β treatment resulted in enhanced human monocytic differentiation in mice engrafted with old HSCs compared to young, consistent with the increased age-dependent myeloid differentiation observed in vitro. Collectively, these findings demonstrate age-associated hypersensitivity of human BM HSCs to IL-1β mediated by enhanced NF-κB responsiveness, providing a framework to understand how aging may reshape hematopoietic responses during inflammatory stress.
Monica Kasbekar, MD, PhD: No relevant conflicts of interest to declare.